mirabegron  - Drug Details
📊 Estimates mirabegron  Dialyzability By Different_Modalities

mirabegron 

Complete Drug Information

Drug Name
mirabegron 
Trade Names
Myrbetriq, Betanis, Betmiga
Pregnancy Category
AU: B3
Bioavailability
29–35%
Routes of Administration
Oral
Protein Binding
71%%
Metabolism
Liver via (direct) glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase
Elimination
50 hours
Excretion
Urine (55%), faeces (34%)
Formula
C21H24N4O2S
Molar Mass
396.51
Volume of Distribution
1670 L/kg

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.